Bristol-Myers Squibb Reports Fourth Quarter and Full Year 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/29/2026
- S&P 500 ends lower; chips tumble and Moderna rallies
- SpaceX weighs Starlink mobile service to US consumers, FT reports
- U.S. chip stocks retreat after Apple price hikes stoke fears over AI trade
- Morgan Stanley flags Fed hike risk if unemployment drops below 4%
- UBS trims AI portfolio exposure to semis and hardware after recent rally
Bristol-Myers Squibb Co. (BMY) PT Lowered to $60 at Jefferies; Says Takeover 'Increasingly Likely'
January 27, 2017 8:26 AM ESTJefferies analyst Jeffrey Holford lowered estimates and his price target on Bristol-Myers Squibb Co. (NYSE: BMY) to $60.00 (from $69.00) but said a takeover increasingly likely as the stock moves towards our ex-lung valuation of $44.
Holford commented, "Management seems to have scared investors... More
Bristol-Myers Squibb (BMY) Extends Losses Mid-Day
January 26, 2017 12:44 PM ESTBristol-Myers Squibb (NYSE: BMY) is seeing notable mid-day weakness following results this morning. The company's earnings call has already ended. Shares are down 4.4%.
... MoreBristol-Myers Squibb (BMY) Misses Q4 EPS by 4c; Guides Below the Street
January 26, 2017 7:00 AM ESTBristol-Myers Squibb (NYSE: BMY) reported Q4 EPS of $0.63, $0.04 worse than the analyst estimate of $0.67. Revenue for the quarter came in at $5.24 billion versus the consensus estimate of $5.13 billion.
GUIDANCE:
Bristol-Myers Squibb sees FY2017 EPS of $2.70-$2.90, versus the consensus of... More
